We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Review · July 10, 2020

Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and CV Disease

JAMA Cardiology

 

Additional Info

JAMA Cardiology
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review
JAMA Cardiol 2020 Jun 17;[EPub Ahead of Print], MC Honigberg, L-S Chang, DK McGuire, J Plutzky, VR Aroda, M Vaduganathan

Further Reading